公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept | Chua K.-N.; Poon K.L.; Lim J.; Sim W.-J.; RUBY YUN-JU HUANG ; Thiery J.P. | Advanced Drug Delivery Reviews | 39 | 37 | |
2012 | Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer | RUBY YUN-JU HUANG ; Chung V.Y.; Thiery J.P. | Current Drug Targets | 66 | 64 | |
2017 | Targeting the AXL signaling pathway in ovarian cancer | RUBY YUN-JU HUANG ; Antony J.; Tan T.Z.; Tan D.S.-P. | Molecular and Cellular Oncology | 13 | 0 | |
2018 | Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis | Shanmugam, Muthu K; Ahn, Kwang Seok; Hsu, Annie; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; RUBY YUN-JU HUANG ; Lim, Lina H K; Sethi, Gautam; Kumar, Alan Prem | Frontiers in pharmacology | 130 | 121 | |
2015 | Transcriptional regulatory loops among SNAI1, TWIST1, ZEB1, and ZEB2 defines the epithelial-mesenchymal transition (EMT) spectrum in epithelial ovarian cancer (EOC) | Tan, M; Chuang, VY; Tan, TZ; Thiery, JP; RUBY YUN-JU HUANG | CANCER RESEARCH | 0 | 0 | |
2010 | Transitions between epithelial and mesenchymal states in microfluidic platform: Acquisition of malignant and stem cell traits | Aref A.R.; RUBY YUN-JU HUANG ; Kang W.; Jing S.W.; Thiery J.P.; Kamm R.D. | Nanotechnology 2010: Electronics, Devices, Fabrication, MEMS, Fluidics and Computational - Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010 | 0 | | |
2018 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer | Antony J.; Zanini E.; Kelly Z.; Tan T.Z.; Karali E.; Alomary M.; Jung Y.; Nixon K.; Cunnea P.; Fotopoulou C.; Paterson A.; Roy-Nawathe S.; Mills G.B.; RUBY YUN-JU HUANG ; Thiery J.P.; Gabra H.; Recchi C. | EMBO Reports | 26 | 29 | |
2020 | Two high-yield complementary methods to sort cell populations by their 2D or 3D migration speed | Arora A.; Ni?o J.L.G.; Myaing M.Z.; Chia S.; Arasi B.; Ravasio A.; RUBY YUN-JU HUANG ; Dasgupta R.; Biro M.; Viasnoff V. | Molecular Biology of the Cell | 1 | 1 | |
2005 | Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-κB pathway by lysophosphatidic acid, an ovarian cancer-activating factor | Chou C.-H; LING-HUNG WEI ; Kuo M.-L; RUBY YUN-JU HUANG ; Lai K.-P; CHI-AN CHEN ; CHANG-YAO HSIEH | Carcinogenesis | 78 | 74 | |
2016 | Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma | Penny H.L.; Sieow J.L.; Adriani G.; Yeap W.H.; See Chi Ee P.; San Luis B.; Lee B.; Lee T.; Mak S.Y.; Ho Y.S.; Lam K.P.; Ong C.K.; RUBY YUN-JU HUANG ; Ginhoux F.; Rotzschke O.; Kamm R.D.; Wong S.C. | OncoImmunology | 161 | 161 | |
2022 | Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer | Ngoi, Natalie Y.L.; Syn, Nicholas L.X.; Goh, Robby M.; Goh, Boon Cher; RUBY YUN-JU HUANG ; Soon, Yu Yang; James, Elizabeth; Cook, Adrian; Clamp, Andrew; Tan, David S.P. | Cochrane Database of Systematic Reviews | 8 | 6 | |